Reading Time: 7 minutesOn 25th April 2023 Tofersen (now known as Qalsody in the US), a treatment for SOD1 MND was approved by the Food and Drug Administration
Month: April 2023
Reading Time: 4 minutesIt is known that people with MND experience different symptoms, and these are not just movement related. People with MND can experience difficulty speaking, breathing